LEUKERAN is indicated in the treatment of: Hodgkin's disease; certain forms of non-Hodgkin's lymphoma; chronic lymphocytic leukaemia; Waldenstrom's macroglobulinaemia.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education